Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?
- PMID: 17612671
- PMCID: PMC1847765
- DOI: 10.1007/BF03085967
Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?
Similar articles
-
Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.Am J Hosp Pharm. 1988 Mar;45(3):570-7. Am J Hosp Pharm. 1988. PMID: 3369459
-
Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.Clin Ther. 2009 Jun;31(6):1209-18. doi: 10.1016/j.clinthera.2009.06.014. Clin Ther. 2009. PMID: 19695388
-
The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.J Surg Res. 2007 Jun 1;140(1):1-5. doi: 10.1016/j.jss.2006.10.010. J Surg Res. 2007. PMID: 17481979 Review.
-
Pharmacist-industry relationships.Int J Pharm Pract. 2017 Dec;25(6):401-410. doi: 10.1111/ijpp.12333. Epub 2017 Jan 18. Int J Pharm Pract. 2017. PMID: 28097713
-
[Career opportunities for female and male physicians in the pharmaceutical industry].Med Klin (Munich). 2000 Jun 15;95(6):322-6. doi: 10.1007/pl00002130. Med Klin (Munich). 2000. PMID: 10935416 Review. German.
Cited by
-
Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias.J Clin Med. 2024 Oct 13;13(20):6099. doi: 10.3390/jcm13206099. J Clin Med. 2024. PMID: 39458049 Free PMC article.
-
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.Europace. 2022 Nov 22;24(11):1809-1823. doi: 10.1093/europace/euac087. Europace. 2022. PMID: 36036670 Free PMC article.
References
-
- The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12. - PubMed
-
- Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet 1997;350:1417-24. - PubMed
-
- Dorian P, Borggreve M, Al-Khalidi, et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646-54. - PubMed
-
- Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004;110:1731-7. - PubMed
LinkOut - more resources
Full Text Sources